These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8842156)

  • 21. Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions.
    Conner JR; Cibas ES; Hornick JL; Qian X
    Cancer Cytopathol; 2014 Aug; 122(8):586-95. PubMed ID: 25044880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of epithelial membrane antigen in the work-up of problematic serous effusions.
    Singh HK; Silverman JF; Berns L; Haddad MG; Park HK
    Diagn Cytopathol; 1995 Jul; 13(1):3-7. PubMed ID: 7587872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrastructure of pleural mesothelioma and pulmonary adenocarcinoma in malignant effusions as compared with reactive mesothelial cells.
    Sakuma N; Kamei T; Ishihara T
    Acta Cytol; 1999; 43(5):777-85. PubMed ID: 10518130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of antimesothelioma HBME-1 in the diagnosis of inflammatory and malignant pleural effusions.
    Mocanu L; Cîmpean AM; Raica M
    Rom J Morphol Embryol; 2006; 47(4):351-5. PubMed ID: 17392981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GLUT1 glucose transporter: a highly sensitive marker of malignancy in body cavity effusions.
    Burstein DE; Reder I; Weiser K; Tong T; Pritsker A; Haber RS
    Mod Pathol; 1998 Apr; 11(4):392-6. PubMed ID: 9578091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis.
    Cury PM; Butcher DN; Corrin B; Nicholson AG
    J Pathol; 1999 Oct; 189(2):251-7. PubMed ID: 10547583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
    Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
    Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 immunostaining as a marker of malignancy in cytologic preparations of body fluids.
    Tiniakos DG; Healicon RM; Hair T; Wadehra V; Horne CH; Angus B
    Acta Cytol; 1995; 39(2):171-6. PubMed ID: 7887063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytologic re-evaluation of negative effusions from patients with malignant mesothelioma.
    Ascoli V; Bosco D; Carnovale Scalzo C
    Pathologica; 2011 Dec; 103(6):318-24. PubMed ID: 22558888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Static DNA cytometry as a diagnostic aid in effusion cytology: II. DNA aneuploidy for identification of neoplastic cells in equivocal effusions.
    Motherby H; Nadjari B; Remmerbach T; Marcy T; Pomjanskaja N; Müller W; Knops K; Häussinger D; Strauer BE; Böcking A
    Anal Quant Cytol Histol; 1998 Jun; 20(3):162-8. PubMed ID: 9642442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
    Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
    Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of two fluorescence in situ hybridization (FISH) probes for diagnosing malignant pleural effusions.
    Rosolen DC; Kulikowski LD; Bottura G; Nascimento AM; Acencio M; Teixeira L; Vargas FS; Sales RK; Antonangelo L
    Lung Cancer; 2013 Jun; 80(3):284-8. PubMed ID: 23453645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ber-EP4 for differentiating adenocarcinoma from reactive and neoplastic mesothelial cells in serous effusions. Comparison with carcinoembryonic antigen, B72.3 and Leu-M1.
    Bailey ME; Brown RW; Mody DR; Cagle P; Ramzy I
    Acta Cytol; 1996; 40(6):1212-6. PubMed ID: 8960030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The negative enrichment by immunomagnetic beads for tumor cells from malignant pleural effusions].
    Yang JJ; Xu XX; Min LF; Lin P; Qian GS
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Sep; 35(9):673-8. PubMed ID: 23158070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose transporter 1 protein detected by enzyme-linked immunosorbent assay and immunocytochemistry: a useful diagnostic tool for malignant pleural effusions.
    Liao ND; Chiang TA; Lee WY
    Cancer Cytopathol; 2013 Dec; 121(12):695-702. PubMed ID: 23861325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential utility of p53 immunopositivity in differentiation of adenocarcinomas from reactive epithelial atypias of the lung.
    Cagle PT; Fraire AE; Greenberg SD; Cox A; Brown RW
    Hum Pathol; 1996 Nov; 27(11):1198-203. PubMed ID: 8912831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
    Afify A; Lynne LC; Howell L
    Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is immunoreactivity for p53 useful in distinguishing benign from malignant effusions? Localization of p53 gene product in benign mesothelial and adenocarcinoma cells.
    Walts AE; Said JW; Koeffler HP
    Mod Pathol; 1994 May; 7(4):462-8. PubMed ID: 8066074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The immunocytochemical study of pleural effusion and ascites using Ber-EP-4 antibodies].
    Spehn J; Iwanetz S; Schmitz-Huebner U
    Dtsch Med Wochenschr; 1995 Sep; 120(36):1197-200. PubMed ID: 7671771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytopathological spectrum of unusual malignant pleural effusions at a tertiary care centre in north India.
    Awasthi A; Gupta N; Srinivasan R; Nijhawan R; Rajwanshi A
    Cytopathology; 2007 Feb; 18(1):28-32. PubMed ID: 17250600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.